Vanguard Group Inc. trimmed its stake in shares of Neogen Corporation (NASDAQ:NEOG – Free Report) by 0.7% in the 4th quarter, HoldingsChannel reports. The firm owned 23,801,905 shares of the company’s stock after selling 161,318 shares during the period. Vanguard Group Inc. owned approximately 0.11% of Neogen worth $166,375,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of NEOG. State of Alaska Department of Revenue lifted its holdings in shares of Neogen by 1.2% in the 4th quarter. State of Alaska Department of Revenue now owns 110,645 shares of the company’s stock valued at $773,000 after purchasing an additional 1,353 shares during the last quarter. Evergreen Capital Management LLC increased its position in Neogen by 12.3% in the 4th quarter. Evergreen Capital Management LLC now owns 13,753 shares of the company’s stock valued at $96,000 after acquiring an additional 1,504 shares during the period. California State Teachers Retirement System increased its position in Neogen by 1.1% in the 2nd quarter. California State Teachers Retirement System now owns 191,084 shares of the company’s stock valued at $913,000 after acquiring an additional 2,166 shares during the period. Sage Rhino Capital LLC increased its position in Neogen by 25.2% in the 3rd quarter. Sage Rhino Capital LLC now owns 16,618 shares of the company’s stock valued at $95,000 after acquiring an additional 3,343 shares during the period. Finally, Mercer Global Advisors Inc. ADV increased its position in Neogen by 27.8% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 16,199 shares of the company’s stock valued at $92,000 after acquiring an additional 3,522 shares during the period. 96.73% of the stock is owned by hedge funds and other institutional investors.
Neogen Price Performance
NEOG stock opened at $9.05 on Monday. Neogen Corporation has a 1 year low of $4.53 and a 1 year high of $11.43. The firm has a market cap of $1.97 billion, a P/E ratio of -3.23, a PEG ratio of 3.93 and a beta of 1.84. The stock’s 50 day moving average price is $9.58 and its 200 day moving average price is $8.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.84 and a current ratio of 3.92.
Analysts Set New Price Targets
Several equities analysts have issued reports on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Neogen in a research report on Friday, April 10th. Wall Street Zen upgraded Neogen from a “hold” rating to a “buy” rating in a research report on Saturday. Piper Sandler reiterated a “neutral” rating and set a $10.00 target price (up from $6.50) on shares of Neogen in a research report on Monday, January 12th. Finally, William Blair reiterated a “market perform” rating on shares of Neogen in a research report on Monday, March 2nd. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Neogen currently has a consensus rating of “Hold” and a consensus target price of $10.67.
View Our Latest Report on Neogen
Neogen Profile
Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.
In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.
Further Reading
- Five stocks we like better than Neogen
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
